Due to its ability to overlay ICG angiographies and FA images for precise planning, Navilas provides a unique and advanced treatment paradigm for central serous chorioretinopathy. In conjunction with the ability to perform subthreshold treatments Navilas represents an optimal tool to target central serous chorioretinopathy.
Indocyanine green angiography images, fluorescein images as well as OCT images can be overlaid to correctly identify the leakage cause and target the appropriate lesion adequately while minimally damaging healthy tissue.
An intertrial study comparison demonstrated that the use of navigated threshold laser results in an earlier and higher closure rate of leakage points as compared to conventional lasers.
Navilas provides full documentation of each applied spot with respect to parameters as well as spot position relative to macula and optical nerve head, thus ensuring for the first time true traceability and enabling potential re-treatment.
With pre-planned laser positions and automatic execution of laser spots it can ensure that the correct tissue is activated and remodeled.
“Navilas allows me to treat CSCR lesions with unprecedented reduction of collateral tissue damage. This is the prerequisite for long-term preservation of vision.“
Dr. Jay Chhablani, UPMC, USA
CSCR - A deep dive into navigated subthreshold laser treatment strategies, with interactive case session using Navigate App
watch webinarOn-demand Webinar: Subthreshold Laser for CSCR
Dr. Nina-Antonia Striebe, University of Göttingen, Germany
watch webinarOn-demand Webinar: Targeting CSCR with Navigated Laser
David M. Brown, MD, FACS
watch webinarComparison of Photodynamic Therapy and Navigated Microsecond Laser for Chronic Central Serous Chorioretinopathy. Ntomoka, Cyprian Gabriel, Bindu Rajesh, Gachago Muchai Muriithi, Abhilash Goud, and Jay Chhablani. Eye, February 12, 2018. PubMed PMID: 29429986
